Correlation Between Rezolute and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Rezolute and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Rezolute and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Lixte Biotechnology.
Diversification Opportunities for Rezolute and Lixte Biotechnology
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rezolute and Lixte is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Rezolute i.e., Rezolute and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Rezolute and Lixte Biotechnology
Given the investment horizon of 90 days Rezolute is expected to generate 0.72 times more return on investment than Lixte Biotechnology. However, Rezolute is 1.39 times less risky than Lixte Biotechnology. It trades about 0.15 of its potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about 0.04 per unit of risk. If you would invest 105.00 in Rezolute on November 3, 2024 and sell it today you would earn a total of 416.00 from holding Rezolute or generate 396.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rezolute vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Rezolute |
| Lixte Biotechnology |
Rezolute and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rezolute and Lixte Biotechnology
The main advantage of trading using opposite Rezolute and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.The idea behind Rezolute and Lixte Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |